BioVie Inc. (BIVI)

CIK 0001580149 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q3-2026 —
Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2024 —
FY-2024 —
Q3-2023 —
Q2-2023 —
Q1-2023 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Balance Sheets
Balance Sheets (P)
Condensedstatements of Operations and Comprehensive Loss (unaudited)
—
Statements of Operations
Statements of Operations and Comprehensive Loss
Statements of Changes In Stockholders' Equity
Statements of Cash Flows
Notes
Background Information
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Benefit Plan
Equity Transactions
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Intangible Assets
Investments In U.s. Treasury Bills Available For Sale
Investments In U.s. Treasury Bills Available-for-sale
—
Leases
Liquidity
—
Liquidity and Going Concern
Notes Payable
Other Liabilities
Pay Vs Performance Disclosure
Related Party Transactions
Segment Reporting
Significant Accounting Policies
Subsequent Events